KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to $31.2 million.

  • Exact Sciences' Capital Expenditures fell 1396.9% to $31.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $134.7 million, marking a year-over-year decrease of 98.02%. This contributed to the annual value of $134.7 million for FY2025, which is 98.02% down from last year.
  • Exact Sciences' Capital Expenditures amounted to $31.2 million in Q4 2025, which was down 1396.9% from $29.9 million recorded in Q3 2025.
  • In the past 5 years, Exact Sciences' Capital Expenditures registered a high of $72.9 million during Q4 2022, and its lowest value of $18.3 million during Q3 2021.
  • For the 5-year period, Exact Sciences' Capital Expenditures averaged around $37.3 million, with its median value being $34.2 million (2022).
  • Per our database at Business Quant, Exact Sciences' Capital Expenditures plummeted by 8364.08% in 2021 and then soared by 14390.47% in 2022.
  • Quarter analysis of 5 years shows Exact Sciences' Capital Expenditures stood at $59.4 million in 2021, then rose by 22.7% to $72.9 million in 2022, then tumbled by 52.08% to $34.9 million in 2023, then rose by 3.99% to $36.3 million in 2024, then dropped by 13.97% to $31.2 million in 2025.
  • Its last three reported values are $31.2 million in Q4 2025, $29.9 million for Q3 2025, and $42.3 million during Q2 2025.